ACA
CORZ

Arena Capital Advisors’s Core Scientific, Inc. Common Stock CORZ Stock Holding History

Arena Capital Advisors’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-916,796
Closed -$10M – 368
2021
Q4 		$10M Sell
916,796
-283,204
-24% -$3.34M 0.92% 24
2021
Q3 		$12.1M Buy
1,200,000
+800,000
+200% +$8.04M 0.96% 28
2021
Q2 		$3.93M Buy
+400,000
New +$3.94M 0.33% 109

Other funds holding CORZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PWM
Perigon Wealth Management San Francisco, California $6.36B AUM 28.76% 1-Year Est. Return
TI
Tidal Investments Milwaukee, Wisconsin $57.8B AUM 72.54% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
KCM
Kensico Capital Management Greenwich, Connecticut $5.83B AUM 42.34% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return

Arena Capital Advisors's CORZ Position: Q1 2022 in Review

Arena Capital Advisors sold out of Core Scientific, Inc. Common Stock (CORZ) in Q1 2022, closing a stake of 916,796 shares — an estimated $10M sold.

Arena Capital Advisors first reported a position in CORZ in Q2 2021 and held it in 3 quarters. The position peaked at $12.1M in Q3 2021. 91 funds tracked by Wall St. Rank hold CORZ as of Q1 2022.

  • Arena Capital Advisors reported no remaining Core Scientific, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Arena Capital Advisors sold 916,796 Core Scientific, Inc. Common Stock shares in Q1 2022, an estimated $10M.
  • Arena Capital Advisors first reported a position in Core Scientific, Inc. Common Stock in Q2 2021 and held it in 3 quarters.
  • Arena Capital Advisors's Core Scientific, Inc. Common Stock position peaked at $12.1M in Q3 2021.
  • 91 funds tracked by Wall St. Rank held Core Scientific, Inc. Common Stock as of Q1 2022.

Based on Arena Capital Advisors's 13F filing for Q1 2022, filed 13 May 2022.